Potential allegations of regulatory misconduct include failure to register and list a medical device, marketing unapproved products and misleading promotion, according to the FDA.
Members of the public can submit complaints through a new online form on the company’s website. While users can report allegations anonymously, the FDA encourages individuals to leave their contact information in case additional information is needed.
The FDA hopes this reporting system will help the agency identify potential patient risks and determine if further investigation is necessary, according to the report.
More articles on supply chain:
Dallas startup allows hospitals to shop online for blood
Where Trump, Clinton stand on medical device tax
FDA approves Immucor’s device to detect sickle cell trait in blood
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
